Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Research and Markets: Commercial Insight: Parkinson's Disease - Japan and Europe to Drive Total Market Growth


Print article Print article
Refer this article Refer to a friend
© Business Wire 2009
2009-10-29 03:05:03 -

Research and Markets ( www.researchandmarkets.com/research/7f327f/commercial_insight : ) has announced the addition of the "Commercial Insight: Parkinson's Disease - Japan and Europe to Drive Total Market Growth" report to their offering.

The Parkinson's disease market is approaching maturity, with the threat of generic incursion evident in each drug class. Although growth will be stifled by generic launches, relatively successful lifecycle management

strategies and new product launches see the Parkinson's disease market grow at a compound annual growth rate (CAGR) of 2.6% over the next 10 years (20082018).

Scope.

- In-depth analysis of the current and future Parkinson's disease market across the US, Japan, France, Germany, Italy, Spain and the UK.


- Parkinson's disease-specific sales forecasts for brands and generics from 2008 to 2018.


- Assessment of the leading Parkinson's disease brands and drug classes to identify key success factors within this market.


- Evaluation of the strategies of leading players in the Parkinson's disease market.

Highlights of this title.

- Stalevo's clear convenience and compliance benefit will see the combination therapy emerge as the market leading brand between 2011 and 2013.


- Although Boehringer Ingelheim is relatively late to the market with a once-daily reformulation, Mirapex/Sifrol's (pramipexole) dominant share of some geographic markets will facilitate a successful launch in 2010.


- Over the 10-year forecast period the US market will lose significance for Parkinson's disease market players as demographic changes and a less competitive commercial environment will see the European and Japanese markets emerge as key generators of growth.

Key reasons to purchase this title.

- Quantify the performance of each of the marketed Parkinson's disease drugs in the seven major markets over the period 2008 to 2018.


- Assess the changing key opportunities and threats affecting current market players and prospective new entrants.


- Identify the leading brands in this market over the next 10 years and understand the key factors driving their success.



Key Topics Covered:

Chapter 1 Executive Summary


Chapter 2 Market Definition


Chapter 3 Market Overview


Chapter 4 Brand Dynamics


Chapter 5 Key Developers


Chapter 6 Case Studies


For more information visit www.researchandmarkets.com/research/7f327f/commercial_insight :

Source: Datamonitor

Research and MarketsLaura Wood, Senior Manager, press@researchandmarkets.com : mailto:press@researchandmarkets.com U.S.

Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716


Disclaimer: (c) 2010 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com